Simbrinza 10 mg/mL + 2 mg/mL Eye drops, suspension

Simbrinza 10 mg/mL + 2 mg/mL Eye drops, suspension

S3
PDF Leaflet Revision Date: 06 February 2023


Clinical Summary

Quick overview from the medicine insert

Indication

Lowering elevated intraocular pressure in glaucoma or ocular hypertension.

Dosage (summary)

One drop in affected eye(s) twice daily for adults.

Special Populations

  • Hepatic impairment
  • Severe renal impairment
  • Elderly

Pregnancy & Breastfeeding

Not recommended in pregnancy or breastfeeding.

Key Drug Interactions

  • Monoamine oxidase inhibitors
  • Tricyclic antidepressants
  • CNS depressants

Contraindications

  • Hypersensitivity to active substances
  • Severe renal impairment
  • Neonates and infants under 2 years

Common side effects

  • Ocular hyperaemia
  • Dysgeusia
  • Ocular allergic reactions

Counselling Points

  • Do not touch dropper tip to avoid contamination.
  • Remove contact lenses before use.
  • Monitor for signs of allergic reactions.

Serious warnings

  • Serious hypersensitivity reactions possible.
  • Caution in patients with cardiovascular disease.

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Simbrinza 10 mg/mL + 2 mg/mL Eye drops, suspension
1/-

Connecting to Document Server

Decrypting and optimizing pharmaceutical leaflet...

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW